PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26029047-8	2015	PB was an efficacious anti-seizure agent at P10 and P12, but not at P7.	Phenobarbital	0-2	S100 calcium binding protein A10 (calpactin)	Mus musculus	44-47	
26029047-9	2015	BTN failed as an adjunct, at all ages tested and significantly blunted PB-efficacy at P10.	Phenobarbital	71-73	S100 calcium binding protein A10 (calpactin)	Mus musculus	86-89	
31864171-1	2020	A recently characterized CD-1 mouse model of phenobarbital (PB)-resistant neonatal ischemic-seizures (i.e.; unilateral carotid ligation) was shown to be associated with age-dependent (P7 vs. P10) acute seizure severity and PB-efficacy (i.e.; PB-resistant vs. PB-responsive).	Phenobarbital	45-58	S100 calcium binding protein A10 (calpactin)	Mus musculus	191-194	
31864171-1	2020	A recently characterized CD-1 mouse model of phenobarbital (PB)-resistant neonatal ischemic-seizures (i.e.; unilateral carotid ligation) was shown to be associated with age-dependent (P7 vs. P10) acute seizure severity and PB-efficacy (i.e.; PB-resistant vs. PB-responsive).	Phenobarbital	60-62	S100 calcium binding protein A10 (calpactin)	Mus musculus	191-194	
31864171-8	2020	ANA12 + PB treatment, but not PB-alone, rescued the loss of gamma power homeostasis present in P7 ligate-control but absent in P10 ligate group, highlighting the age-dependence.	Phenobarbital	8-10	S100 calcium binding protein A10 (calpactin)	Mus musculus	127-130	
31864171-9	2020	In contrast, PB-alone treatment, but not ANA12+PB, significantly reduced the elevated delta-AUC observed in P10 ligate-controls, when PB is efficacious by itself.	Phenobarbital	13-15	S100 calcium binding protein A10 (calpactin)	Mus musculus	108-111